BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

360 related articles for article (PubMed ID: 7182986)

  • 1. Succinylacetone inhibits delta-aminolevulinate dehydratase and potentiates the drug and steroid induction of delta-aminolevulinate synthase in liver.
    Sassa S; Kappas A
    Trans Assoc Am Physicians; 1982; 95():42-52. PubMed ID: 7182986
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hereditary tyrosinemia and the heme biosynthetic pathway. Profound inhibition of delta-aminolevulinic acid dehydratase activity by succinylacetone.
    Sassa S; Kappas A
    J Clin Invest; 1983 Mar; 71(3):625-34. PubMed ID: 6826727
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Succinylacetone and delta-aminolevulinic acid dehydratase in hereditary tyrosinemia: immunochemical study of the enzyme.
    Sassa S; Fujita H; Kappas A
    Pediatrics; 1990 Jul; 86(1):84-6. PubMed ID: 2359685
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of succinylacetone (4,6-dioxoheptanoic acid) on delta-aminolevulinate synthase activity and the content of heme in monolayers of chick embryo liver cells.
    Schoenfeld N; Greenblat Y; Epstein O; Atsmon A
    Biochim Biophys Acta; 1982 Dec; 721(4):408-17. PubMed ID: 7159602
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of succinylacetone on heme and cytochrome P450 synthesis in hepatocyte culture.
    Giger U; Meyer UA
    FEBS Lett; 1983 Mar; 153(2):335-8. PubMed ID: 6617864
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of succinylacetone and the use of its measurement in mass screening for hereditary tyrosinemia.
    Grenier A; Lescault A; Laberge C; Gagné R; Mamer O
    Clin Chim Acta; 1982 Aug; 123(1-2):93-9. PubMed ID: 7116642
    [TBL] [Abstract][Full Text] [Related]  

  • 7. On the enzymic defects in hereditary tyrosinemia.
    Lindblad B; Lindstedt S; Steen G
    Proc Natl Acad Sci U S A; 1977 Oct; 74(10):4641-5. PubMed ID: 270706
    [TBL] [Abstract][Full Text] [Related]  

  • 8. On rat renal aminolevulinate transport and metabolism in experimental Fanconi syndrome.
    Roth KS; Carter BE; Moses LC; Spencer PD
    Biochem Med Metab Biol; 1990 Dec; 44(3):238-46. PubMed ID: 2288767
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Concentrations of succinylacetone after homogentisate and tyrosine loading in healthy individuals with low fumarylacetoacetase activity.
    Kvittingen EA; Leonard JV; Pettit BR; King GS
    Clin Chim Acta; 1985 Nov; 152(3):271-9. PubMed ID: 4064334
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of delta-aminolevulinic acid synthase and delta-aminolevulinic acid dehydratase in normal human bone marrow cultures.
    Shionoya S; Urabe A; Hashimoto Y; Kondo M; Urata G
    Stem Cells (1981); 1982; 2(3):145-54. PubMed ID: 7163916
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diphenyl diselenide and diphenyl ditelluride differentially affect delta-aminolevulinate dehydratase from liver, kidney, and brain of mice.
    Maciel EN; Bolzan RC; Braga AL; Rocha JB
    J Biochem Mol Toxicol; 2000; 14(6):310-9. PubMed ID: 11083084
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biochemical studies on the enzymatic deficiencies in hereditary tyrosinemia.
    Berger R; van Faassen H; Smith GP
    Clin Chim Acta; 1983 Oct; 134(1-2):129-41. PubMed ID: 6652907
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Succinylacetone, a potent inhibitor of heme biosynthesis: effect on cell growth, heme content and delta-aminolevulinic acid dehydratase activity of malignant murine erythroleukemia cells.
    Ebert PS; Hess RA; Frykholm BC; Tschudy DP
    Biochem Biophys Res Commun; 1979 Jun; 88(4):1382-90. PubMed ID: 289386
    [No Abstract]   [Full Text] [Related]  

  • 14. Contribution of extrahepatic tissues to biochemical abnormalities in hereditary tyrosinemia type I: study of three patients after liver transplantation.
    Tuchman M; Freese DK; Sharp HL; Ramnaraine ML; Ascher N; Bloomer JR
    J Pediatr; 1987 Mar; 110(3):399-403. PubMed ID: 3546650
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alteration of activities of delta-aminolevulinic acid synthase, delta-aminolevulinic acid dehydratase and delta-aminolevulinic acid dehydratase inhibitor in the bone marrow cells of lead poisoned rats.
    Kondo M; Kajimoto M; Urata G
    Exp Hematol; 1983 Apr; 11(4):324-31. PubMed ID: 6840227
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Control of hemoglobin synthesis in erythroid differentiating K562 cells. I. Role of iron in erythroid cell heme synthesis.
    Kawasaki N; Morimoto K; Tanimoto T; Hayakawa T
    Arch Biochem Biophys; 1996 Apr; 328(2):289-94. PubMed ID: 8645006
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [delta-Aminolevulinate dehydratase deficiency].
    Fujita H; Ishida N; Akagi R
    Nihon Rinsho; 1995 Jun; 53(6):1408-17. PubMed ID: 7616655
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cadmium inhibits delta-aminolevulinate dehydratase from rat lung in vitro: interaction with chelating and antioxidant agents.
    Luchese C; Zeni G; Rocha JB; Nogueira CW; Santos FW
    Chem Biol Interact; 2007 Jan; 165(2):127-37. PubMed ID: 17187767
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of ethanol and diphenyl diselenide exposure on the activity of delta-aminolevulinate dehydratase from mouse liver and brain.
    Fachinetto R; Pivetta LA; Farina M; Pereira RP; Nogueira CW; Rocha JB
    Food Chem Toxicol; 2006 Apr; 44(4):588-94. PubMed ID: 16364531
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hereditary tyrosinemia. Formation of succinylacetone-amino acid adducts.
    Manabe S; Sassa S; Kappas A
    J Exp Med; 1985 Sep; 162(3):1060-74. PubMed ID: 3928801
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.